Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Prevention of Ovarian Cancer in Women Participating in Mammography [NA]
This clinical trial update reports the completion of a study evaluating prevention of ovarian cancer in women participating in mammography.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
This completed Phase 1/Phase 2 study evaluated the feasibility and safety of combining carboplatin-based chemotherapy (carboplatin with Cael…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma [Phase 1]
This Phase 1 trial assesses dose escalation of cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery in patients w…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating a combination of intravenous and intraperitoneal paclitaxel, intraperitoneal cisplatin, and intravenous be…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas [Phase 2]
Phase 2 trial of sunitinib in metastatic, locally advanced, or locally recurrent sarcomas completed; results posted in 2016 and include desm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer [EARLY_Phase 1]
An early-phase cancer screening trial for women at high risk of ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer [Phase 1]
Phase 1 safety study of an antisense product in multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer [Phase 2]
MITO-5 is a Phase 2 trial evaluating weekly carboplatin and paclitaxel as first-line chemotherapy for elderly patients with ovarian cancer. …
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer [Phase 2]
A Phase 2 study (MITO-6) tested capecitabine in platinum-resistant ovarian cancer and the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial adding AMG 479 to first-line chemotherapy for optimally debulked epithelial ovarian cancer was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy in patients with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy [Phase 3]
A Phase 3 trial comparing carboplatin alone versus carboplatin with gemcitabine in patients with advanced epithelial ovarian cancer that has…
-
CLINICAL_TRIALS withdrawal · 2015-12-23Clinical Trial Update: BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients [Phase 1, Phase 2]
The Phase 1/2 clinical trial of BNC105P in partially platinum-sensitive ovarian cancer patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel [Phase 2]
Phase 2 trial update evaluating Ombrabulin in platinum-sensitive recurrent ovarian cancer patients treated with carboplatin and paclitaxel. …
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer [Phase 1]
A Phase I safety study of a cancer vaccine for HLA-A2 positive advanced ovarian, breast, and prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases [Phase 1]
Phase 1 clinical trial update on EMD 525797 for colorectal and ovarian cancer patients with liver metastases; study status is completed with…
-
CLINICAL_TRIALS research · 2015-12-10Clinical Trial Update: Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
This entry reports a completed clinical trial focused on collecting tissue samples from patients with stage III or stage IV ovarian epitheli…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]
ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer [Phase 1]
This clinical trial update reports completion of a Phase 1 pivotal bioequivalence study of the liposomal doxorubicin formulation DOXIL/CAELY…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of pemetrexed disodium and docetaxel in patients with advanced solid tumors has completed, studyi…
-
CLINICAL_TRIALS research · 2015-12-03Clinical Trial Update: Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer [Phase 1, Phase 2]
ClinicalTrials.gov update for OVAX, an autologous hapten-modified vaccine, in relapsed stage III/IV ovarian cancer; the Phase 1/Phase 2 tria…
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Interactive Educational Website for Women With Ovarian Cancer & Caregivers [EARLY_Phase 1]
This document reports the completion of an EARLY Phase 1 clinical trial evaluating an interactive educational website for women with ovarian…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer [Phase 2]
Phase 2 study of AMG 479 as second-line therapy for recurrent platinum-sensitive ovarian cancer has completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-27Clinical Trial Update: Oxaliplatin and Topotecan in Advance Ovarian Cancer [Phase 2]
A Phase 2 trial of oxaliplatin and topotecan in advanced or recurrent ovarian cancer was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Sexual Functioning After Primary Treatment of Ovarian Cancer
A clinical trial investigating sexual functioning after primary treatment of ovarian cancer was terminated.